Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000463590 | SCV000556208 | likely benign | Multiple endocrine neoplasia, type 2 | 2023-12-08 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000463590 | SCV004830677 | likely benign | Multiple endocrine neoplasia, type 2 | 2023-12-01 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004791478 | SCV005403642 | benign | Multiple endocrine neoplasia type 2A | 2024-09-05 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is intronic and is not expected to impact mRNA splicing. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. |